{
    "2020-05-27": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Sanofi's Dupixent Gets FDA Approval for Eczema in Children",
                "features": {
                    "keywords": [
                        "Dupixent",
                        "FDA Approval",
                        "Eczema",
                        "Children"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Dividend",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Zacks.com featured highlights include: Eli Lilly and Company, Quidel, Everbridge and Sprouts Farmers Market",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Quidel",
                        "Everbridge",
                        "Sprouts Farmers Market"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "retail"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "White House announces plan for Medicare enrollees to get insulin for $35 a month",
                "features": {
                    "keywords": [
                        "White House",
                        "Medicare",
                        "insulin",
                        "$35"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government policy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Eli Lilly's COVID-19 therapy development partner AbCellera raises $105 million",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "COVID-19",
                        "AbCellera",
                        "$105 million"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19",
                "features": {
                    "keywords": [
                        "AbCellera",
                        "Antibody drug",
                        "COVID-19",
                        "$105 million"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}